Influence of Therapeutic Education in Patients With Joint Inflammation Treated With a Biological Treatment — ALSASP  

Non-radiographic Spondyloarthritis Clinical Trial

Official title: Impact of a Therapeutic Education Program in Patients With Non-radiological Spondyloarthritis Treated With Anti-tumor Necrosis Factor (TNF)

Status Recruiting

Clinical Trial Summary

To describe, with a patient reported score (BIOSECURE), the influence of an approved therapeutic education program (TEP) in patients with joint inflammation requiring a biological treatment initiation.

The hypothesis is that patients attending the TEP will display better cognitive and adaptation competences than patients with no TEP.

Patient's reported quality of life, disease related stress management, treatment adherence, socio-demographic factors, biological home administration modalities and if the biologic treatment is maintained at 12 months, will also be described.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Non-radiographic Spondyloarthritis
• Spondylarthritis

• NCT number: NCT03360864
• Study type: Interventional
• Source: University Hospital, Strasbourg, France
• Contact: Christelle SORDET, MD
• Phone: 3 88 12 81 16
• Email: christelle.sordet@chru-strasbourg.fr
• Status: Recruiting
• Phase: N/A
• Start date: January 16, 2020
• Completion date: January 16, 2023